As Biopharma Giants Reshape the Field, Cognition Therapeutics Sees a Place for Its Alzheimer’s Drug
GEN,
Lisa Ricciardi, Cognition Therapeutics president and CEO By Alex Philippidis With Eisai and Biogen winning full FDA approval in…
Lisa Ricciardi, Cognition Therapeutics president and CEO By Alex Philippidis With Eisai and Biogen winning full FDA approval in…
By Deborah Borfitz June 21, 2023 | The latest report on clinical trials in the Alzheimer’s drug development pipeline points to…
Cada año se registran 10 millones de casos de demencia en el mundo, la mayoría de alzhéimer.
Shutterstock / sfam_photo Ana García Osta, Universidad de Navarra y Mar Cuadrado Tejedor, Universidad de Navarra Cada año se…